Welcome to the UPF Digital Repository

CB1 cannabinoid receptors mediate cognitive deficits and structural plasticity changes during nicotine withdrawal

Show simple item record

dc.contributor.author Saravia, Rocío
dc.contributor.author Flores de los Heros, África, 1985-
dc.contributor.author Plaza-Zabala, Ainhoa, 1982-
dc.contributor.author Busquets Garcia, Arnau, 1985-
dc.contributor.author Pastor, Antonio
dc.contributor.author Torre Fornell, Rafael de la
dc.contributor.author Di Marzo, Vicenzo
dc.contributor.author Marsicano, Giovanni
dc.contributor.author Ozaita Mintegui, Andrés, 1969-
dc.contributor.author Maldonado, Rafael, 1961-
dc.contributor.author Berrendero Díaz, Fernando, 1971-
dc.date.accessioned 2017-04-20T07:19:29Z
dc.date.issued 2017
dc.identifier.citation Saravia R, Flores de los Heros Á, Plaza-Zabala A, Busquets Garcia A, Pastor A, de la Torre R et al. CB1 cannabinoid receptors mediate cognitive deficits and structural plasticity changes during nicotine withdrawal. Biol Psychiatry. 2017 Apr 1;81(7):625-34. DOI: 10.1016/j.biopsych.2016.07.007
dc.identifier.issn 0006-3223
dc.identifier.uri http://hdl.handle.net/10230/30842
dc.description.abstract BACKGROUND: Tobacco withdrawal is associated with deficits in cognitive function, including attention, working memory, and episodic memory. Understanding the neurobiological mechanisms involved in these effects is crucial because cognitive deficits during nicotine withdrawal may predict relapse in humans. METHODS: We investigated in mice the role of CB1 cannabinoid receptors (CB1Rs) in memory impairment and spine density changes induced by nicotine withdrawal precipitated by the nicotinic antagonist mecamylamine. Drugs acting on the endocannabinoid system and genetically modified mice were used. RESULTS: Memory impairment during nicotine withdrawal was blocked by the CB1R antagonist rimonabant or the genetic deletion of CB1R in forebrain gamma-aminobutyric acidergic (GABAergic) neurons (GABA-CB1R). An increase of 2-arachidonoylglycerol (2-AG), but not anandamide, was observed during nicotine withdrawal. The selective inhibitor of 2-AG biosynthesis O7460 abolished cognitive deficits of nicotine abstinence, whereas the inhibitor of 2-AG enzymatic degradation JZL184 did not produce any effect in cognitive impairment. Moreover, memory impairment was prevented by the selective mammalian target of rapamycin inhibitor temsirolimus and the protein synthesis inhibitor anisomycin. Mature dendritic spines on CA1 pyramidal hippocampal neurons decreased 4 days after the precipitation of nicotine withdrawal, when the cognitive deficits were still present. Indeed, a correlation between memory performance and mature spine density was found. Interestingly, these structural plasticity alterations were normalized in GABA-CB1R conditional knockout mice and after subchronic treatment with rimonabant. CONCLUSIONS: These findings underline the interest of CB1R as a target to improve cognitive performance during early nicotine withdrawal. Cognitive deficits in early abstinence are associated with increased relapse risk.
dc.description.sponsorship This work was supported by the Ministerio de Economía y Competitividad-MINECO (Grant No. SAF2014-59648-P to RM and Grant Nos. BFU2012-33500 and BFU2015-68568-P to AO), the Instituto de Salud Carlos III (Grant No. PI13/00042 to FB and RETICS-RTA, Grant No. RD12/0028/0023 to RM), the Generalitat de Catalunya-AGAUR (Grant No. 2014-SGR-1547 to RM), Plan Nacional sobre Drogas (Grant No. 2014I019 to FB), the European Commission (NeuroPain, Grant No. HEALTH-F2-2013-602891 to RM), FP7-PEOPLE-2013-IEF-623638, and French State/Agence Nationale de la Recherche/IdEx (Grant No. ANR-10-IDEX-03-02 to AB-G)
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Biological Psychiatry. 2017 Apr 1;81(7):625-34
dc.rights © Elsevier http://dx.doi.org/10.1016/j.biopsych.2016.07.007
dc.title CB1 cannabinoid receptors mediate cognitive deficits and structural plasticity changes during nicotine withdrawal
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.biopsych.2016.07.007
dc.subject.keyword Tabaquisme -- Tractament
dc.subject.keyword Cannabinoides -- Receptors
dc.subject.keyword Trastorns de la cognició
dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/623638
dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/602891
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


Compliant to Partaking